Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

2017; Elsevier BV; Volume: 130; Issue: 3 Linguagem: Inglês

10.1182/blood-2016-12-758383

ISSN

1528-0020

Autores

Pier Luigi Zinzani, Vincent Ribrag, Craig H. Moskowitz, Jean‐Marie Michot, John Kuruvilla, Arun Balakumaran, Yayan Zhang, Sabine Chlosta, Margaret A. Shipp, Philippe Armand,

Tópico(s)

Cancer Immunotherapy and Biomarkers

Referência(s)